• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本地方自治体实施的前列腺癌筛查中癌症检出率的地域差异。

Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan.

机构信息

School of Medicine, University of Tsukuba, Tsukuba, Japan.

出版信息

Prostate Int. 2014 Mar;2(1):19-25. doi: 10.12954/PI.13035. Epub 2014 Mar 30.

DOI:10.12954/PI.13035
PMID:24693530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3970985/
Abstract

PURPOSE

We conducted the present retrospective study to elucidate regional differences in the quality of secondary screening in the prostate cancer (PCA) screening program by a local municipality in Japan.

METHODS

Of 115,881 men who attended the PCA screening in 36 municipalities between 2001 and 2011, a total of 6,099 men consulted hospitals for secondary screening. The cancer detection rate (CDR) at the secondary screening was calculated, and municipalities were classified into three CDR groups according to the age-adjusted observed-to-expected ratios of CDR. Of the secondary screening facilities, hospitals in Ibaraki Prefecture screening less than 100 patients were classified as group I facilities and the others as group II facilities.

RESULTS

Overall, 2,320 of 6,099 secondary screening patients underwent prostate biopsy, and 1,073 men were diagnosed with PCA. The overall CDR at the secondary screening was 17.6%, but it varied from 5.6% to 34.4% among municipalities. Although there were no significant differences in age and prostate-specific antigen (PSA) distribution among the three CDR groups, a significantly higher rate of patients in low CDR municipalities visited group I facilities. Both biopsy rates and CDRs of secondary screening at group II facilities were significantly higher than those of group I facilities (P=0.0001). Multivariate analysis showed that the secondary screening at group II facilities as well as age and PSA levels were independent contributing factors for PCA detection.

CONCLUSIONS

CDRs at secondary screening varied widely among municipalities in Ibaraki Prefecture. Variation in CDRs was associated with biopsy rates.

摘要

目的

本研究回顾性分析了日本某地方政府前列腺癌(PCA)筛查项目中二次筛查的质量在地域上的差异。

方法

在 2001 年至 2011 年间,共有 115881 名男性参加了 36 个市的 PCA 筛查,其中共有 6099 名男性到医院进行了二次筛查。计算了二次筛查的癌症检出率(CDR),并根据 CDR 的年龄调整观察到的预期比值,将各自治市分为三组。在二次筛查机构中,茨城县筛查少于 100 名患者的医院被归类为组 I 机构,其余为组 II 机构。

结果

共有 6099 名二次筛查患者中的 2320 名接受了前列腺活检,1073 名男性被诊断为 PCA。二次筛查的总体 CDR 为 17.6%,但在各自治市之间从 5.6%到 34.4%不等。尽管三组 CDR 之间的年龄和前列腺特异性抗原(PSA)分布无显著差异,但低 CDR 自治市的患者中,更多的人选择了组 I 机构就诊。组 II 机构的活检率和二次筛查的 CDR 均明显高于组 I 机构(P=0.0001)。多变量分析显示,组 II 机构的二次筛查以及年龄和 PSA 水平是 PCA 检出的独立影响因素。

结论

茨城县各自治市的二次筛查 CDR 差异很大。CDR 的差异与活检率有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/71cb4b516176/pi-2-1-19-4f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/59fa5288bbb5/pi-2-1-19-4f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/b259539ebe28/pi-2-1-19-4f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/340bdf8a12d4/pi-2-1-19-4f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/71cb4b516176/pi-2-1-19-4f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/59fa5288bbb5/pi-2-1-19-4f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/b259539ebe28/pi-2-1-19-4f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/340bdf8a12d4/pi-2-1-19-4f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c530/3970985/71cb4b516176/pi-2-1-19-4f4.jpg

相似文献

1
Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan.日本地方自治体实施的前列腺癌筛查中癌症检出率的地域差异。
Prostate Int. 2014 Mar;2(1):19-25. doi: 10.12954/PI.13035. Epub 2014 Mar 30.
2
Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice.比较在真实世界实践中前列腺特异性抗原水平<10.0ng/ml 的患者采用各种前列腺活检方法的前列腺癌检出率。
Investig Clin Urol. 2020 Jan;61(1):28-34. doi: 10.4111/icu.2020.61.1.28. Epub 2019 Nov 28.
3
Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan.在日本滋贺县草津市,基于人群的前列腺特异性抗原前列腺癌筛查可能通过机会性检测对早期发现产生间接影响。
Mol Clin Oncol. 2022 Nov 23;18(1):3. doi: 10.3892/mco.2022.2599. eCollection 2023 Jan.
4
Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.在前列腺癌筛查中使用低游离 PSA 与总 PSA 比值:血清 PSA 水平<4.0ng/mL 的巴西男性中的检出率、临床和病理发现。
BJU Int. 2012 Dec;110(11 Pt B):E653-7. doi: 10.1111/j.1464-410X.2012.11398.x. Epub 2012 Aug 14.
5
A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection.经会阴电磁跟踪磁共振成像/超声融合引导活检队列:评估读者间变异性对癌症检出率的影响。
BJU Int. 2020 Apr;125(4):531-540. doi: 10.1111/bju.14957. Epub 2019 Dec 23.
6
The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.直肠指检在肥胖患者前列腺癌检测中作为诊断试验的作用。
J BUON. 2015 Nov-Dec;20(6):1601-5.
7
Mass screening of prostate cancer in Changchun City of China.中国长春市前列腺癌的大规模筛查。
Int Urol Nephrol. 2004;36(4):541-8. doi: 10.1007/s11255-004-0842-0.
8
Prostate-specific antigen screening coverage and prostate cancer incidence rates in the Belgian province of Limburg in 1996-1998.
Eur J Cancer Prev. 2002 Dec;11(6):547-9. doi: 10.1097/00008469-200212000-00007.
9
Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019.1985年至2019年芬兰前列腺癌发病率和死亡率地理差异的周期性趋势。
Acta Oncol. 2022 Oct;61(10):1209-1215. doi: 10.1080/0284186X.2022.2112971. Epub 2022 Aug 25.
10
Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.基于前列腺特异性抗原的前列腺癌早期检测——无需直肠指检的筛查验证
Urology. 2001 Jan;57(1):83-90. doi: 10.1016/s0090-4295(00)00863-3.

本文引用的文献

1
Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial.前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中,前列腺癌筛查检测呈阳性后的种族与随访诊断护理之间的关联。
Cancer. 2013 Jun 15;119(12):2223-9. doi: 10.1002/cncr.28042. Epub 2013 Apr 4.
2
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.全球低危前列腺癌的主动监测:PRIAS 研究。
Eur Urol. 2013 Apr;63(4):597-603. doi: 10.1016/j.eururo.2012.11.005. Epub 2012 Nov 12.
3
Practice patterns of Korean urologists for screening and managing prostate cancer according to PSA level.
韩国泌尿科医生根据 PSA 水平进行前列腺癌筛查和管理的实践模式。
Yonsei Med J. 2012 Nov 1;53(6):1136-41. doi: 10.3349/ymj.2012.53.6.1136.
4
Active surveillance for prostate cancer in a veteran population.退伍军人人群中前列腺癌的主动监测。
Can J Urol. 2010 Dec;17(6):5429-35.
5
PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.前列腺特异性抗原水平和各中心的癌症检出率在欧洲前列腺癌筛查随机研究中。
Eur J Cancer. 2010 Nov;46(17):3053-60. doi: 10.1016/j.ejca.2010.09.012.
6
Prostate Cancer Working Group report.前列腺癌工作组报告。
Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i70-75. doi: 10.1093/jjco/hyq130.
7
Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010.2010 年日本泌尿外科学会前列腺癌基于前列腺特异性抗原筛查指南更新版。
Int J Urol. 2010 Oct;17(10):830-8. doi: 10.1111/j.1442-2042.2010.02613.x.
8
Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006.2004-2006 年国家癌症数据库中男性前列腺癌诊断患者的保险状况和种族/民族与疾病严重程度的关系。
Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2437-44. doi: 10.1158/1055-9965.EPI-10-0299. Epub 2010 Aug 12.
9
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.